摘要
中国已进入老龄化社会,共病是老年人群较为突出的公共健康问题。总结梳理老年人群共病领域研究现状,分析探讨相应策略对于老年共病人群的临床综合管理具有重要意义。本文重点从共病管理研究实践、共病诊疗模式、共病用药策略、共病医护团队及健康管理服务体系建设方面分析了该领域研究现状,同时提出建立以患者为中心的共病管理研究方案、推广应用老年共病评估工具、开展共病共有病因及机制研究、制订共病管理规范性指南/共识、借鉴中医学“以证统病”“整体观念”思想、融合互联网+技术与智能可穿戴设备及开展共病早期风险评估与管理等应对策略,综合展望共病领域后期研究方向,以期为该领域进一步深入研究提供参考。
Multimorbidity has become a prominent public health problem in older people in China as the country reached an aging society.Summarizing the studies in multimorbidity in elderly population and analyzing and discussing the coping strategies are of great significance for comprehensive management of this group of people.Herein,we reviewed the latest studies about multimorbidity in older people involving management practice,diagnosis and treatment model,medication strategy,and the building of medical and nursing team and health management system.Besides that,we summarized the following coping strategies:establishing a patient-centered multimorbidity management research program,promoting the application of geriatric multimorbidity assessment tools,conduct research on the common etiology and pathogenesis of comorbidity,developing standardized guidelines/consensuses on multimorbidity management,formulating treatment schemes using the TCM ideas of"treating diseases according to syndrome"and"holistic treatment",Internet technologies and smart wearable devices,and conducting early risk assessment and management of multimorbidity.In addition,we provided a comprehensive outlook on future research directions.All this is aimed at providing a reference for further in-depth research in this field.
作者
章轶立
黄馨懿
齐保玉
孙传睿
王晓阳
魏戌
谢雁鸣
ZHANG Yili;HUANG Xinyi;QI Baoyu;SUN Chuanrui;WANG Xiaoyang;WEI Xu;XIE Yanming(School of Traditional Chinese Medicine&School of Integrated Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China;School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China;Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China;Shaanxi University of Chinese Medicine,Xianyang 712046,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处
《中国全科医学》
CAS
北大核心
2022年第35期4363-4368,共6页
Chinese General Practice
基金
中国中医药循证医学中心“业务研究室主任专项”(2020YJSZX-4)
中国中医科学院科技创新工程重大攻关项目(CI2021A02013)
江苏高校优势学科建设工程资助项目(PAPD)
南京中医药大学特聘教授启动资金项目
南京中医药大学罗林秀基金项目(LLX202205)
江苏省科技计划专项基金(基础研究计划自然科学基金)(BK20220468)。
